Home › Funds › Fidelity National Financial, Inc. › ABT

Fidelity National Financial, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Fidelity National Financial, Inc. reported holding 223,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 0.84% of its reported portfolio and ranking #11 among its reported holdings. Fidelity National Financial, Inc. has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)223.00K sh
Reported value held$22.04M
Portfolio Weight0.84%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Fidelity National Financial, Inc.'s ABT position evolved

Fidelity National Financial, Inc. first disclosed a stake in ABT in Q2 2026 at 223,000 shares (US$20.2M). The position peaked in Q3 2026 at 223,000 shares, worth US$22.0M. Across 2 filings, Fidelity National Financial, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 223,000 shares valued at US$22.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 223.00K $20.24M New
Q3 2026 223.00K $22.04M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Fidelity National Financial, Inc. held ABT?

Fidelity National Financial, Inc. has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Fidelity National Financial, Inc.'s current position in ABT?

As of Q3 2026, Fidelity National Financial, Inc. holds 223.00K shares of ABT (ABBOTT LABORATORIES), valued at $22.04M, representing 0.84% of its reported portfolio and ranking #11.

Has Fidelity National Financial, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Fidelity National Financial, Inc. held unchanged its position in ABT. The position peaked in Q3 2026 at 223.00K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.